HB 374 Delaware House · 149th General Assembly (2017-2018)

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE MEDICAL MARIJUANA ACT.

Summary
This bill adds glaucoma, chronic debilitating migraines, pediatric autism spectrum disorder, pediatric sensory processing disorder to the list of debilitating medical conditions which may qualify a person, upon certification by a physician, to be eligible for the use of medical marijuana in accordance with the terms of the Delaware Medical Marijuana Act.
Bill status signed all 5 stages cleared
Introduction
Apr 2018
Committee Review
Jun 2018
House Passage
May 2018
Senate Passage
Jun 2018
Signed into Law
Aug 2018
Introduced Apr 17, 2018 Signed Aug 28, 2018
Floor votes · House May 1, 2018

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
9
Key actions
6
Committee
2
Amendments
2
Aug 28, 2018
Signed into law
Signed by Governor
executive
Jun 20, 2018
Upper · Passed
Passed By Senate. Votes: 19 YES 2 ABSENT
upper
Jun 6, 2018
Upper · Passed
Reported Out of Committee (Health, Children & Social Services) in Senate with 5 On Its Merits
upper
May 3, 2018
Introduced
Assigned to Health, Children & Social Services Committee in Senate
upper
May 1, 2018
Lower · Passed
Passed By House. Votes: 41 YES
lower
May 1, 2018
Lower · Passed
Amendment HA 1 to HB 374 - Passed In House by Voice Vote
lower
Apr 25, 2018
Lower · Passed
Reported Out of Committee (Health & Human Development) in House with 9 On Its Merits
lower
Apr 25, 2018
Introduced
Amendment HA 1 to HB 374 - Introduced and Placed With Bill
lower
Apr 17, 2018
Introduced
Introduced and Assigned to Health & Human Development Committee in House
lower
4 primary · 20 co-sponsors

Sponsors